Acumen Hypotension Prediction Index (HPI) Feature Software vs Zio XT ECG Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Acumen Hypotension Prediction Index (HPI) Feature Software
by Edwards Lifesciences
VS
Zio XT ECG Monitoring System
by iRhythm Technologies, Inc.

AI Verdict

These two tools are adjacent in the broader healthcare-AI landscape, both leveraging AI in cardiology but for distinct purposes. Acumen HPI is designed for real-time, predictive management of hypotension in acute care settings, while the Zio XT system offers extended ambulatory ECG monitoring for arrhythmia detection and diagnosis. Clinicians would choose between them based on the immediate need for hemodynamic stability prediction versus long-term cardiac rhythm assessment.

Choose Acumen Hypotension Prediction Index (HPI) Feature Software if…

Choose Acumen Hypotension Prediction Index (HPI) if your primary goal is to proactively prevent and manage acute hypotensive events in critically ill or surgical patients. This tool is ideal for real-time, high-acuity environments like the OR or ICU, where its predictive analytics can alert clinicians to impending hemodynamic instability up to 15 minutes in advance, enabling timely intervention.

View Acumen Hypotension Prediction Index (HPI) Feature Software →

Choose Zio XT ECG Monitoring System if…

Choose Zio XT ECG Monitoring System if you require extended, continuous cardiac monitoring for patients experiencing intermittent arrhythmias or needing ambulatory ECG assessment over several days. This wearable system is best suited for outpatient settings where patient comfort, compliance, and accurate detection of elusive cardiac events over a period of up to 14 days are paramount.

View Zio XT ECG Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Acumen Hypotension Prediction Index (HPI) Feature Software Zio XT ECG Monitoring System
Pricing Unknown Contact for pricing
Deployment Unknown Cloud-based (AWS EC2 platform), no on-premise hardware required.
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Acumen Hypotension Prediction Index (HPI) Feature Software Zio XT ECG Monitoring System
Tool Name Acumen Hypotension Prediction Index (HPI) Feature Software Zio XT ECG Monitoring System
Company Edwards Lifesciences iRhythm Technologies
Primary Use Case Predictive monitoring to detect and alert clinicians to the likelihood of a hypotensive event before it occurs, aiding in proactive hemodynamic management. Wearable, single-lead ECG biosensor for up to 14 days of continuous cardiac monitoring, utilizing FDA-cleared AI and expert review for accurate arrhythmia detection and diagnosis.
Core Technology Machine learning algorithms for predictive analysis of blood pressure waveforms; HPI parameter (0-100 score). Wearable single-lead ECG biosensor; proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis.
Monitoring/Prediction Scope Predicts hypotension up to 15 minutes before an event. Continuous ambulatory cardiac monitoring for up to 14 days.

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index (HPI) Feature Software and Zio XT ECG Monitoring System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Acumen HPI software is designed for proactive hemodynamic management, detecting and alerting clinicians to the likelihood of a hypotensive event up to 15 minutes before it occurs, primarily for patients in anesthesiology, critical care, and emergency medicine. Zio XT, on the other hand, provides continuous cardiac monitoring for up to 14 days to detect and diagnose arrhythmias, targeting specialties such as cardiology, emergency medicine, and internal medicine.
The Acumen HPI software uses machine learning algorithms to analyze blood pressure waveforms and predict the likelihood of an impending hypotensive event, providing a Hypotension Prediction Index (HPI) score. The Zio XT system employs a proprietary, FDA-cleared deep-learned AI algorithm to analyze continuous ECG data for accurate arrhythmia detection and diagnosis.
Acumen HPI collects and analyzes blood pressure waveforms to provide an HPI score and insights into preload, afterload, and contractility, requiring either invasive (arterial line) or non-invasive (Acumen IQ cuff) blood pressure monitoring. Zio XT utilizes a wearable single-lead ECG biosensor to continuously monitor cardiac electrical activity for up to 14 days, detecting arrhythmias.
The Acumen HPI software provides continuous, real-time predictive monitoring for hemodynamic instability in acute care environments, with the HPI parameter updated every 20 seconds. The Zio XT ECG Monitoring System offers continuous ambulatory cardiac monitoring for an extended period, up to 14 days.
Acumen HPI provides a 0-100 HPI parameter score, Smart Alerts for impending hypotensive events, and a Relationship View screen offering insights into preload, afterload, and contractility. Zio XT delivers comprehensive reports based on its AI analysis and expert review of continuous ECG data, aiding in arrhythmia detection and diagnosis.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Acumen Hypotension Prediction Index (HPI) Feature Software or Zio XT ECG Monitoring System

Backers

Who funded each tool's parent company.

Zio XT ECG Monitoring System

AI Tool Finder
AI-powered search. Results may not be comprehensive.